In a post hoc analysis of a stepped-wedge cluster trial of 446 patients with stage I–IV lung cancer, weekly online symptom reporting vs usual care had median overall survival of 26 vs 21 months (adjusted HR 0·80, 95% CI 0·63–1·00); progression-free survival did not differ.
Secondary analysisn = 446
Hassing et al. Patient-reported symptom monitoring in patients with lung cancer (SYMPRO-Lung trial): long-term, post-hoc survival results of a multicentre, stepped-wedged, cluster-randomised clinical trial